Immunization therapy for Alzheimer disease: A comprehensive review of active immunization strategies

Tohoku Journal of Experimental Medicine

Volumn 220, Issue 2, 2010, Pages 95-106

  Tabira, Takeshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Alzheimer; Autoimmune; Immunotherapy; T helper 1; T helper 2; Vaccine

Indexed keywords

ACC 001; ADENOVIRUS VECTOR; ADJUVANT; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-11]; AMYLOID BETA PROTEIN[1-15]; AMYLOID BETA PROTEIN[1-16]; AMYLOID BETA PROTEIN[1-21]; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[1-43]; AMYLOID BETA PROTEIN[3-6]; BETA SECRETASE; CHOLERA TOXIN B SUBUNIT; DNA VACCINE; GLATIRAMER; INTERLEUKIN 10; INTERLEUKIN 4; IVX 908; MACROPHAGE DERIVED CHEMOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PARVOVIRUS VECTOR; PEPTIDE VACCINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTOLLIN; QS 21; RECOMBINANT VACCINE; SHI QUAN DA BU TANG; UNCLASSIFIED DRUG; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ADENOVIRUS; ALZHEIMER DISEASE; ANTIBODY RESPONSE; AUTOPSY; BACTERIOPHAGE; CLINICAL TRIAL; COGNITION; DISEASE COURSE; DRUG MECHANISM; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; MENINGOENCEPHALITIS; MULTIPLE SCLEROSIS; MURINE LEUKEMIA VIRUS; NONHUMAN; PASSIVE IMMUNIZATION; PLASMID; POTATO; REVIEW; SALMONELLA; SENDAI VIRUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOMATO; VACCINATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOTHERAPY, ACTIVE;

EID: 77949431000     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.220.95     Document Type: Review

References (65)

1. Agadjanyan, M.G., Ghochikyan, A., Petrushina, I., Vasilevko, V., Movsesyan, N., Mkrtichyan, M., Saing, T. & Cribbs, D.H. (2005) Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. J. Immunol., 174, 1580-1586.
2. Bach, P., Tschäpe, J.A., Kopietz, F., Braun, G., Baade, J.K., Wiederhold, K.H., Staufenbiel, M., Prinz, M., Deller, T., Kalinke, U., Buchholz, C.J. & Müller, U.C. (2009) Vaccination with Aβ-displaying virus-like particles reduces soluble and insoluble cerebral Aβ and lowers plaque burden in APP transgenic mice. J. Immunol., 182, 7613-7624.
3. Bard, F., Cannon, C., Barbour, R., Burke, R.L., Games, D., Grajeda H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D. & Yednock, T. (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med., 6, 916-919.
4. Bard, F., Barbour, R., Cannon, C., Carretto, R., Fox, M., Games, D., Guido, T., Hoenow, K., Hu, K., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, C., Lee, M., Motter, R., Nguyen, M., Reed, A., Schenk, D., Tang, P., Vasquez, N., Seubert, P. & Yednock, T. (2003) Epitope and isotype specificities of antibodies to β-amyloid peptide against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci. USA, 100, 2023-2028.
5. Boutajangout, A., Goni, F., Knudsen, E., Schreiber, F., Asuni, A., Quartermain, D., Frangione, B., Chabalgoity, A., Wisniewski, T. & Sigurdsson, E.M. (2009) Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a Salmonella-based amyloid-beta derivative vaccine. J. Alzheimers Dis., 18, 961-972.
6. Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H. & Schwartz, M. (2006) Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA, 103, 11784-11789.
7. Chang, W.P., Downs, D., Huang, X.P., Da, H., Fung, K.M. & Tang, J. (2007) Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization. FASEB J., 21, 3184-3196.
8. DaSilva, K.A., Brown, M.E. & McLaurin, J. (2009) Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine. Vaccine, 27, 1365-1376.
9. Ferrer, I., Boada Rovira, M., Sánchez Guerra, M.L., Rey, M.J. & Costa-Jussá, F. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol., 14, 11-20.
10. Frazer, M.E., Hughes, J.E., Mastrangelo, M.A., Tibbens, J.L., Federoff, H.J. & Bowers, W.J. (2008) Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4. Mol. Ther., 16, 845-853.
11. Frenkel, D., Katz, O. & Solomon, B. (2000) Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. USA, 97, 11455-11459.
12. Frenkel, D., Maron, R., Burt, D.S. & Weiner, H.L. (2005) Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest., 115, 2423-2433.
13. Friedland, R.P., Tedesco, J.M., Wilson, A.C., Atwood, C.S., Smith, M.A., Perry, G. & Zagorski, M.G. (2008) Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. J. Biol. Chem., 283, 22550-22556.
14. Gilman, S., Koller, M., Black, R.S., Jenkins, L., Griffith, S.G., Fox, N.C., Eisner, L., Kirby, L., Rovira, M.B., Forette, F. & Orgogozo, J.M.; AN1792(QS-21)-201 Study Team. (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 64, 1553-1562.
15. Ghochikyan, A., Petrushina, I., Lees, A., Vasilevko, V. , Movsesyan, N., Karapetyan, A., Agadjanyan, M.G. & Cribbs, D.H. (2006) Aβ-imunotherapy for Alzheimer's disease using Mannan-amyloid-beta peptide imunoconjugates. DNA Cell Biol., 25, 571-580.
16. Götz, J., Chen, F., van Dorpe, J. & Nitsch, R.M. (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science, 293, 1491-1495.
17. Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E. & Hyman, B.T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., 41, 17-24.
18. Hardy, J. & Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
19. Hara, H., Kataoka, S., Anan, M., Ueda, A., Mutoh, T. & Tabira, T. (2010) The therapeutic effects of herbal medicine, Juzen-taiho-to on the reduction of Aβ burden in a mouse model of Alzheimer's disease. J. Alzheimers Dis., [in press].
20. Hara, H., Monsonego, A., Yuasa, K., Adachi, K., Xiao, X., Takeda, S., Takahashi, K., Weiner, H.L. & Tabira, T. (2004) Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J. Alzheimers Dis., 6, 483-488.
21. Hara, H. & Tabira, T. (2006) Oral Aβ vaccine using Adeno-associated virus vector for Alzheimer's disease. In Current Topics in Neuroimmunology, edited by T. Tabira, T. Yamamura & J. Kira. Medimond, Bologna, pp. 129-137.
22. Harigaya, Y., Saido, T.C., Eckman, C.B., Prada, C.M., Shoji, M. & Younkin, S.G. (2000) Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochem. Biophys. Res. Commun., 276, 422-427.
23. Hasegawa, T., Mikoda, N., Kitazawa, M. & LaFerla, F.M. (2010) Treatment of Alzheimer's disease with anti-homocysteic acid antibody in 3xTg-AD male mice. PLoS One, 5, e8593.
24. Hock, C., Konietzko, U., Streffer, J.R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., Wollmer, M.A., Umbricht, D., de Quervain, D.J., Hofmann, M., Maddalena, A., Papassotiropoulos, A. & Nitsch, R.M. (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron, 38, 547-554.
25. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R.W., Bullock, R., Love, S., Neal, J.W., Zotova, E. & Nicoll, J.A. (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial. Lancet, 372, 216-223.
26. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y. , Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St George-Hyslop, P. & Westaway, D. (2000) Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 408, 979-982.
27. Kim, H.D., Jin, J.J., Maxwell, J.A. & Fukuchi, K. (2007a) Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease. Immunol. Lett., 112, 30-38.
28. Kim, H.D., Tahara, K., Maxwell, J.A., Lalonde, R., Fukuiwa, T., Fujihashi, K., Van Kampen, K.R., Kong, F.K., Tang, D.C. & Fukuchi, K. (2007b) Nasal inoculation of an adenovirus encoding 11 tandem repeats of Aβ1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPsw PS1dE9 mouse model of Alzheimer disease. J. Gene Med., 9, 88-98.
29. 1-42 trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA, 302, 1796-1802.
30. Lavie, V., Becker, M., Cohen-Kupiec, R., Yacoby, I., Koppel, R., Wedenig, M., Hutter-Paier, B., & Solomon, B. (2004) EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris Water Maze trials. J. Mol. Neurosci., 24, 105-113.
31. Liu, H., Wang, J., Sekiyama, A. & Tabira, T. (2008) Juzen-taiho-to, an herbal medicine, activates and enhances phagocytosis in microglia/ macrophages. Tohoku J. Exp. Med., 215, 43-54.
32. Maier, M., Seabrook, T.J., Lazo, N.D., Jiang, L., Das, P., Janus, C. & Lemere, C.A. (2006) Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. J. Neurosci., 26, 4717-4728.
33. Masliah, E., Hansen, L., Adame, A., Crews, L., Bard, F., Lee, C., Seubert, P. , Games, D., Kirby, L. & Schenk, D. (2005) Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology, 64, 129-131.
34. Matsui, Y., Tanizaki, Y., Arima, H., Yonemoto, K., Doi, Y. , Ninomiya, T., Sasaki, K., Iida, M., Iwaki, T., Kanba, S. & Kiyohara, Y. (2009) Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J. Neurol. Neurosurg. Psychiatry, 80, 366-370.
35. Monsonego, A., Imitola, J., Petrovic, S., Zota, V. , Nemirovsky, A., Baron, R., Fisher, Y. , Owens, T. & Weiner, H.L. (2006) Abeta-induced meningoencephalitis is IFN-gamma- dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 103, 5048-5053.
36. Monsonego, A., Maron, R., Zota, V. , Selkoe, D.J. & Weiner, H.L. (2001) Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 98, 10273-10278.
37. Monsonego, A., Zota, V. , Karni, A., Krieger, J.I., Bar-Or, A., Bitan, G., Budson, A.E., Sperling, R., Selkoe, D.J. & Weiner, H.L. (2003) Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest., 112, 415-422.
38. Morgan, D., Diamond, D.M., Gottschall, P.E., Ugen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M. & Arendash, G.W. (2000) Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 408, 982-985.
39. Mouri, A., Noda, Y., Hara, H., Mizoguchi, H., Tabira, T. & Nabeshima, T. (2007) Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J., 21, 2135-2148.
40. Movsesyan, N., Ghochikyan, A., Mkrtichyan, M., Petrushina, I., Davtyan, H., Olkhanud, P.B., Head, E., Biragyn, A., Cribbs, D.H. & Agadjanyan, M.G. (2008) Reducing AD-like pathology in 3 x Tg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy. PLoS One, 3, e2124.
41. Muhs, A., Hickman, D.T., Pihlgren, M., Chuard, N., Giriens, V., Meerschman, C., van der Auwera, I., van Leuven, F., Sugawara, M., Weingertner, M.C., Bechinger, B., Greferath, R., Kolonko, N., Nagel-Steger, L., Riesner, D., Brady, R.O., Pfeifer, A. & Nicolau, C. (2007) Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proc. Natl. Acad. Sci. USA, 104, 9810-9815.
42. Nicoll, J.A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. & Weller, R.O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med., 9, 448-452.
43. Nikolic, W.V., Bai, Y. , Obregon, D., Hou, H., Mori, T., Zeng, J., Ehrhart, J., Shytle, R.D., Giunta, B., Morgan, D., Town, T. & Tan, J. (2007) Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhage. Proc. Natl. Acad. Sci. USA, 104, 2507-2512.
44. Noguchi, A., Matsumura, S., Dezawa, M., Tada, M., Yanazawa, M., Ito, A., Akioka, M., Kikuchi, S., Sato, M., Ideno, S., Noda, M., Fukunari, A., Muramatsu, S., Itokazu, Y. , Sato, K., Takahashi, H., Teplow, D.B., Nabeshima, Y. , Kakita, A., Imahori, K. & Hoshi, M. (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J. Biol. Chem., 284, 32895-32905.
45. Okura, Y., Miyakoshi, A., Kohyama, K., Park, I.K., Staufenbiel, M. & Matsumoto, Y. (2006) Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety. Proc. Natl. Acad. Sci. USA, 103, 9619-9624.
46. Orgogozo, J.M., Gilman, S., Dartigues, J.F., Laurent, B., Puel, M., Kirby, L.C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B.F., Boada, M., Frank, A. & Hock, C. (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology, 61, 46-54.
47. Petrushina, I., Ghochikyan, A., Mkrtichyan, M., Mamikonyan, G., Movsesyan, N., Ajdari, R., Vasilevko, V., Karapetyan, A., Lees, A., Agadjanyan, M.G. & Cribbs, D.H. (2008) Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J. Neuroinflammation, 5, 42.
48. Qu, B., Rosenberg, R.N., Li, L., Boyer, P.J. & Johnston, S.A. (2004) Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch. Neurol., 61, 1859-1864.
49. Qu, B.X., Xiang, Q., Li, L., Johnston, S.A., Hynan, L.S. & Rosenberg, R.N. (2007) Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice. J. Neurol. Sci., 260, 204-213.
50. Rakover, I., Arbel, M. & Solomon, B. (2007) Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain Abeta levels. Neurodegener. Dis., 4, 392-402.
51. Ribé, E.M., Pérez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S., Sánchez, B., Nieto, M., Gómez-Ramos, P., Morán, M.A., Cabodevilla, F., Samaranch, L., Ortiz, L., Pérez, A., Ferrer, I., Avila, J. & Gómez-Isla, T. (2005) Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis., 20, 814-822.
52. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D. & Seubert, P. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173-177.
53. Schneeberger, A., Mandler, M., Otawa, O., Zauner, W., Mattner, F. & Schmidt, W. (2009) Development of AFFITOPE vaccines for Alzheimer's disease (AD) - from concept to clinical testing. J. Nutr. Health Aging, 13, 264-267.
54. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P. & Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 49, 489-502.
55. Tabira, T. (2004) Molecular basis of Alzhiemer's disease: from amyloid hypothesis to treatment in the foreseeable future. Geriatr. Gerontol. Int., 4, S27-31.
56. Tabira, T., Chui, D.H. & Kuroda, S. (2002) Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front. Biosci., 7, a44-49.
57. Vellas, B., Black, R., Thal, L.J., Fox, N.C., Daniels, M., McLennan, G., Tompkins, C., Leibman, C., Pomfret, M. & Grundman, M.; AN1792 (QS-21)-251 Study Team. (2009) Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr. Alzheimer Res., 6, 144-151.
58. Wada-Isoe, K., Uemura, Y., Suto, Y., Doi, K., Imamura, K., Hayashi, A., Kitayama, M., Watanabe, Y. , Adachi, Y. & Nakashima, K. (2009) Prevalence of dementia in the rural island town of Ama-cho, Japan. Neuroepidemiology, 32, 101-106.
59. Weiner, H.L. & Frenkel, D. (2006) Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol., 6, 404-416.
60. Weiner, H.L., Lemere, C.A., Maron, R., Spooner, E.T., Grenfell, T.J., Mori, C., Issazadeh, S., Hancock, W.W. & Selkoe, D.J. (2000) Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol., 48, 567-579.
61. Wilcock, D.M., Gharkholonarehe, N., Van Nostrand, W.E., Davis, J., Vitek, M.P. & Colton, C.A. (2009) Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease. J. Neurosci., 29, 7957-7965.
62. Wisniewski, K.E., Wisniewski, H.M. & Wen, G.Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol., 17, 278-282.
63. Youm, J.W., Jeon, J.H., Kim, H., Kim, Y.H., Ko, K., Joung, H. & Kim, H. (2008) Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease. Biotechnol. Lett., 30, 1839-1845.
64. Youm, J.W., Kim, H., Han, J.H., Jang, C.H., Ha, H.J., Mook-Jung, I., Jeon, J.H., Choi, C.Y., Kim, Y.H., Kim, H.S. & Joung, H. (2005) Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model. FEBS Lett., 579, 6737-6744.
65. Zhang, J., Wu, X., Qin, C., Qi, J., Ma, S., Zhang, H., Kong, Q., Chen, D., Ba, D. & He, W. (2003) A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease. Neurobiol. Dis., 14, 365-379.